CD36 (CD36 Molecule) - A Multifunctional Scavenger Receptor in Lipid Metabolism and Immunity
Comprehensive gene overview of CD36, a key fatty acid transporter and pattern recognition receptor implicated in metabolic disorders, cardiovascular disease, and cancer.
Gene Information Card
| Symbol | CD36 |
|---|---|
| Full Name | CD36 Molecule (CD36 antigen, fatty acid translocase) |
| Gene Type | Protein coding |
| Chromosomal Location | 7q21.11 |
| NCBI Gene ID | 948 ncbi.nlm.nih.gov/gene/948 |
| Ensembl ID | ENSG00000135218 |
| UniProt ID | P16671 |
| OMIM ID | 173510 |
| HGNC ID | 1663 |
| Aliases | FAT, GP3B, GP4, GPIV, SCARB3, CHDS7, PAS-4, BDPLT10 |
Description
The CD36 gene encodes a heavily glycosylated, integral membrane protein belonging to the class B scavenger receptor family. CD36 functions as a multifunctional receptor that binds a diverse range of ligands, including long-chain fatty acids, oxidized low-density lipoproteins (oxLDL), thrombospondin, collagen, and apoptotic cells. It plays a critical role in fatty acid uptake and transport, lipid metabolism, innate immunity, and angiogenesis. CD36 is expressed on various cell types, including platelets, monocytes/macrophages, adipocytes, skeletal and cardiac muscle cells, and endothelial cells. Genetic variations in CD36 are associated with platelet glycoprotein deficiency, metabolic syndrome, and susceptibility to malaria.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Platelet Glycoprotein IV Deficiency (CD36 deficiency) | Loss-of-function mutations in CD36 lead to a lack of CD36 protein on platelets and monocytes, impairing platelet adhesion and function. | OMIM #173510; ClinVar |
| Coronary Artery Disease / Myocardial Infarction | CD36 mediates uptake of oxidized LDL in macrophages, contributing to foam cell formation and atherosclerotic plaque development. Polymorphisms may alter lipid metabolism and cardiovascular risk. | NCBI Gene; OMIM |
| Metabolic Syndrome / Insulin Resistance | CD36 facilitates fatty acid uptake in muscle and adipose tissue. Altered expression or function is linked to dyslipidemia, ectopic lipid accumulation, and impaired insulin signaling. | UniProt; NCBI Gene |
| Malaria (Cerebral) | CD36 serves as a receptor for Plasmodium falciparum-infected erythrocytes on endothelial cells, contributing to cytoadherence and severe malaria pathogenesis. | OMIM; NCBI Gene |
| Cancer (e.g., Oral Squamous Cell Carcinoma) | CD36 expression on tumor-initiating cells is associated with lipid metabolism and metastasis, promoting tumor progression via fatty acid uptake. | COSMIC; NCBI Gene |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Adipose Tissue | High | High |
| Skeletal Muscle | High | High |
| Heart | High | High |
| Liver | Low | Low |
| Bone Marrow | Medium | Medium |
| Lung | Medium | Medium |
| Spleen | Medium | Medium |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| Macrophages | High | Key scavenger receptor for oxLDL uptake |
| Platelets | High | Mediates platelet adhesion and thrombus formation |
| Adipocytes | High | Primary fatty acid transporter |
| HepG2 (Liver) | Low | Low endogenous expression |
| THP-1 (Monocyte) | Medium | Upregulated upon differentiation to macrophages |
| Caco-2 (Intestinal) | Medium | Involved in fatty acid absorption |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.268C>T (p.Arg90Ter) | Nonsense | Rare | Loss of function; causes CD36 deficiency |
| c.949G>A (p.Gly317Ser) | Missense | Rare | Impaired fatty acid uptake; associated with metabolic syndrome |
| c.1159C>T (p.Arg387Cys) | Missense | Rare | Reduced cell surface expression; linked to platelet deficiency |
| c.329-330del (p.Leu110fs) | Frameshift | Very rare | Loss of function; leads to complete CD36 deficiency |
Mutation functional classification
Loss of Function (LOF)
Most CD36 mutations are loss-of-function, leading to reduced or absent protein expression on the cell surface. This results in impaired fatty acid transport, defective platelet function, and increased susceptibility to certain infections.
Gain of Function (GOF)
Gain-of-function mutations are rare and not well characterized. Some polymorphisms may lead to increased CD36 expression or ligand affinity, potentially contributing to excessive lipid uptake and foam cell formation in atherosclerosis.
Dominant Negative (DN)
No clear dominant-negative mutations have been reported for CD36. The protein functions as a homodimer, and most pathogenic variants act in a recessive manner, with heterozygous carriers often showing reduced but not absent expression.
View complete mutation data:
Gene Ontology (GO)
| • GO:0005044 - scavenger receptor activity | • GO:0005326 - long-chain fatty acid transporter activity |
| • GO:0005515 - protein binding | • GO:0005886 - plasma membrane |
| • GO:0006629 - lipid metabolic process | • GO:0006915 - apoptotic process |
| • GO:0007155 - cell adhesion | • GO:0009897 - external side of plasma membrane |
| • GO:0016021 - integral component of membrane | • GO:0030168 - platelet activation |
| • GO:0034364 - high-density lipoprotein particle | • GO:0050766 - positive regulation of phagocytosis |
Pathways
• Fatty acid metabolism
• PPAR signaling pathway
• Scavenger receptor pathway
• Toll-like receptor signaling (modulation)
• VEGF signaling (angiogenesis)
• Platelet activation
Protein Summary
CD36 is a 471-amino acid single-pass type III membrane glycoprotein with a molecular weight of approximately 53 kDa (glycosylated form ~88 kDa). It has a short cytoplasmic N-terminus, a large extracellular loop, and a short cytoplasmic C-terminus. The extracellular domain contains multiple ligand-binding sites and is heavily N-glycosylated. CD36 functions as a homodimer and is localized to lipid rafts on the plasma membrane. It binds long-chain fatty acids with high affinity and facilitates their transport across the membrane. In macrophages, CD36 mediates the uptake of oxidized LDL, leading to foam cell formation. It also acts as a pattern recognition receptor for bacterial and fungal pathogens. The protein is involved in platelet adhesion to collagen and thrombospondin, and in the clearance of apoptotic cells. CD36 undergoes post-translational modifications including palmitoylation and ubiquitination, which regulate its trafficking and degradation.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CD36 Knockout HEK293 Cell Line | EDJ-KQ1885 | Human | 948 | Details Get a Quote |
| CD36 Knockout HeLa Cell Line | EDJ-KQ52836 | Human | 948 | Details Get a Quote |
| CD36 Knockout A-549 Cell Line | EDJ-KQ61306 | Human | 948 | Details Get a Quote |
| CD36 Knockout HCT 116 Cell Line | EDJ-KQ69800 | Human | 948 | Details Get a Quote |
| CD36 Overexpression HEK293 Stable Cell Line | EDJ-GQ91 | Human | 948 | Details Get a Quote |
| CD36 Overexpression HEK293T Stable Cell Line | EDJ-GQ92 | Human | 948 | Details Get a Quote |
Displaying Records 1 To 6 Of 6 Records